Stock Research: Bumrungrad Hospital

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Bumrungrad Hospital

SET:BH TH0168A10Z01
83
  • Value
    44
  • Growth
    27
  • Safety
    Safety
    100
  • Combined
    70
  • Sentiment
    94
  • 360° View
    360° View
    83
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Bumrungrad Hospital Public Company Limited is a healthcare provider offering holistic services to outpatients and inpatients. It primarily operates a private hospital in Bangkok, providing a wide range of healthcare services including Telemedicine, preventive genomics, family check-ups, Bumrungrad@Home services, breast health, and sports medicine. It operates in Thailand and Southeast Asia. In the last fiscal year, the company had a market cap of $3531 million, profits of $383 million, revenue of $748 million, and 4234 employees.

more
Index
SET
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
44 37 30 19
Growth
27 19 61 57
Safety
Safety
100 100 100 60
Sentiment
94 63 96 72
360° View
360° View
83 63 96 57
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
64 55 44 19
Opinions Change
63 36 56 67
Pro Holdings
n/a 61 100 46
Market Pulse
93 94 95 89
Sentiment
94 63 96 72
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
44 37 30 19
Growth
27 19 61 57
Safety Safety
100 100 100 60
Combined
70 55 88 34
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
61 55 43 9
Price vs. Earnings (P/E)
33 27 14 13
Price vs. Book (P/B)
34 21 15 22
Dividend Yield
73 78 76 75
Value
44 37 30 19
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
6 4 4 84
Profit Growth
23 25 75 17
Capital Growth
100 98 100 38
Stock Returns
29 19 37 55
Growth
27 19 61 57
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
96 98 96 70
Refinancing
59 51 47 39
Liquidity
98 98 98 53
Safety Safety
100 100 100 60

Similar Stocks

Discover high‑ranked alternatives to Bumrungrad Hospital and broaden your portfolio horizons.

Vodacom

JSE:VOD
Country: South Africa
Industry: Wireless Telecommunication
Size: X-Large
Full Stock Analysis

Cipla

NSEI:CIPLA
Country: India
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

Fleury

BOVESPA:FLRY3
Country: Brazil
Industry: Health Care Services
Size: Medium
Full Stock Analysis

Kalbe Farma

IDX:KLBF
Country: Indonesia
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

The value case is weak (expensive and low Growth Rank), but sentiment is strong and financing is safe. This scenario may indicate future growth not yet in current financials. This is a speculative choice for investors with a high-risk appetite who are betting on the positive sentiment and safe financing to sustain a long-term turnaround.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: